Suppr超能文献

糖尿病肾病中肾小管上皮细胞的改变。

Alterations in tubular epithelial cells in diabetic nephropathy.

作者信息

Habib Samy L

机构信息

Geriatric Research, Education and Clinical Department, South Texas Veterans Health Care System and Cellular and Structural Biology Department, University of Texas Health Science Center, San Antonio, TX - USA.

出版信息

J Nephrol. 2013 Sep-Oct;26(5):865-9. doi: 10.5301/jn.5000287. Epub 2013 Aug 6.

Abstract

Renal hypertrophy, matrix protein accumulation and tubulointerstitial fibrosis are major pathological features of diabetic nephropathy (DN) that eventuate in renal failure. Hyperglycemia and high concentration of glucose increase matrix protein expression, but the pathogenic mechanisms are not fully understood. We have previously reported that inactivation of tuberin resulting in activation of the mammalian target of rapamycin (mTOR) pathway and increased matrix protein accumulation in cultured proximal tubular cells exposed to high glucose and in kidney cortex of rats with type 1 diabetes. In this report, we show that kidney sections of diabetic patients express higher levels of phospho-tuberin (inactive form of tuberin), and that is associated with an increase in mTOR activation as measured by phosphorylation level of p70S6K. Inactivation of tuberin and activation of mTOR lead to accumulated cell matrix proteins (fibronectin and collagen IV) mainly in tubular epithelial cells of the kidneys of diabetic patients. In addition, significant staining of vimentin as a marker of cells undergoing an epithelial-to-mesenchymal transition (EMT) was detected in kidney sections of diabetic patients. On the other hand, very weak or nondetectable staining of cell matrix proteins, p-tuberin and P-p70S6K as well as vimentin was found in normal kidney sections of healthy subjects. The morphological changes in kidney sections of diabetic patients showed tubular thickening, glomerular and tubular hypertrophy, compared to normal structure of tubuli and glomeruli in kidney from healthy control subjects. These data suggest that alterations in tubular cells' structure, including tubular thickening and hypertrophy, are major mediators of the fibrotic process in DN.

摘要

肾肥大、基质蛋白积聚和肾小管间质纤维化是糖尿病肾病(DN)的主要病理特征,最终会导致肾衰竭。高血糖和高浓度葡萄糖会增加基质蛋白表达,但其致病机制尚未完全明确。我们之前报道过,在高糖环境下培养的近端肾小管细胞以及1型糖尿病大鼠的肾皮质中,结节性硬化蛋白失活会导致雷帕霉素靶蛋白(mTOR)通路激活,进而增加基质蛋白积聚。在本报告中,我们发现糖尿病患者的肾切片中磷酸化结节性硬化蛋白(结节性硬化蛋白的失活形式)表达水平更高,且这与通过p70S6K磷酸化水平测得的mTOR激活增加有关。结节性硬化蛋白失活和mTOR激活主要导致糖尿病患者肾脏肾小管上皮细胞中细胞基质蛋白(纤连蛋白和IV型胶原)积聚。此外,在糖尿病患者的肾切片中检测到波形蛋白有明显染色,波形蛋白是上皮-间质转化(EMT)细胞的标志物。另一方面,在健康受试者的正常肾切片中,细胞基质蛋白、磷酸化结节性硬化蛋白和磷酸化p70S6K以及波形蛋白的染色非常弱或未检测到。与健康对照受试者肾脏中肾小管和肾小球的正常结构相比,糖尿病患者肾切片的形态学变化表现为肾小管增厚、肾小球和肾小管肥大。这些数据表明,肾小管细胞结构的改变,包括肾小管增厚和肥大,是糖尿病肾病纤维化过程的主要介导因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验